Yazdanpanah Y - Search Results

1

Increased bleeding in HIV-positive haemophiliac patients treated with lopinavir-ritonavir.

Yazdanpanah Y, Viget N, Cheret A, Guerroumi H, Gerard Y, Ajana F, Caron J, Mouton Y. Yazdanpanah Y, et al. AIDS. 2003 Nov 7;17(16):2397-9. doi: 10.1097/00002030-200311070-00017. AIDS. 2003. PMID: 14571194 No abstract available.

2

Hyperlactataemia during antiretroviral therapy: incidences, clinical data and treatment.

Gérard Y, Viget N, Yazdanpanah Y, Ajana F, de La Tribonnière X, Bocket L, Deuffic-Burban S, Dos Santos A, Ballester L, Mouton Y. Gérard Y, et al. Among authors: yazdanpanah y. Therapie. 2003 Mar-Apr;58(2):153-8. doi: 10.2515/therapie:2003022. Therapie. 2003. PMID: 12942856 Clinical Trial.

3

Characteristics of and outcomes in HIV-infected patients who return to care after loss to follow-up.

Ndiaye B, Ould-Kaci K, Salleron J, Bataille P, Bonnevie F, Cochonat K, Fontier C, Guerroumi H, Yazdanpanah Y. Ndiaye B, et al. Among authors: yazdanpanah y. AIDS. 2009 Aug 24;23(13):1786-9. doi: 10.1097/QAD.0b013e32832e3469. AIDS. 2009. PMID: 19531927

4

[Mitochondrial cytopathies associated with HIV infection].

Gérard Y, Melliez H, Mouton Y, Yazdanpanah Y. Gérard Y, et al. Among authors: yazdanpanah y. Rev Neurol (Paris). 2006 Jan;162(1):62-70. doi: 10.1016/s0035-3787(06)74983-9. Rev Neurol (Paris). 2006. PMID: 16446624 Review. French.

5

Lifetime cost of HIV care in France during the era of highly active antiretroviral therapy.

Yazdanpanah Y, Goldie SJ, Losina E, Weinstein MC, Lebrun T, Paltiel AD, Seage GR 3rd, Leblanc G, Ajana F, Kimmel AD, Zhang H, Salamon R, Mouton Y, Freedberg KA. Yazdanpanah Y, et al. Antivir Ther. 2002 Dec;7(4):257-66. Antivir Ther. 2002. PMID: 12553480

6

Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.

Bahr GM, De La Tribonniere X, Darcissac E, Ajana F, Bocket L, Sissoko D, Yazdanpanah Y, Dewulf J, Amiel C, Mouton Y. Bahr GM, et al. Among authors: yazdanpanah y. J Antimicrob Chemother. 2003 Jun;51(6):1377-88. doi: 10.1093/jac/dkg244. Epub 2003 Apr 25. J Antimicrob Chemother. 2003. PMID: 12716777 Clinical Trial.

7

Incidence rate and risk factors for loss to follow-up in a French clinical cohort of HIV-infected patients from January 1985 to January 1998.

Lebouché B, Yazdanpanah Y, Gérard Y, Sissoko D, Ajana F, Alcaraz I, Boitte P, Cadoré B, Mouton Y. Lebouché B, et al. Among authors: yazdanpanah y. HIV Med. 2006 Apr;7(3):140-5. doi: 10.1111/j.1468-1293.2006.00357.x. HIV Med. 2006. PMID: 16494627 Free article.

8

Incidence of and risk factors for severe liver toxicity in HIV-infected patients on anti-tuberculosis treatment.

Pukenyte E, Lescure FX, Rey D, Rabaud C, Hoen B, Chavanet P, Laiskonis AP, Schmit JL, May T, Mouton Y, Yazdanpanah Y. Pukenyte E, et al. Among authors: yazdanpanah y. Int J Tuberc Lung Dis. 2007 Jan;11(1):78-84. Int J Tuberc Lung Dis. 2007. PMID: 17217134

9

[Morbidity and cost of rotavirus infections in France].

Melliez H, Boelle PY, Baron S, Mouton Y, Yazdanpanah Y. Melliez H, et al. Among authors: yazdanpanah y. Med Mal Infect. 2005 Oct;35(10):492-9. doi: 10.1016/j.medmal.2005.08.007. Epub 2005 Nov 28. Med Mal Infect. 2005. PMID: 16316731 French.

10

Effectiveness of childhood vaccination against rotavirus in sub-Saharan Africa: the case of Nigeria.

Melliez H, Boelle PY, Baron S, Mouton Y, Yazdanpanah Y. Melliez H, et al. Among authors: yazdanpanah y. Vaccine. 2007 Jan 4;25(2):298-305. doi: 10.1016/j.vaccine.2006.07.038. Epub 2006 Aug 7. Vaccine. 2007. PMID: 17055130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

740 results

Search Page

Filters